Skip to main content
. 2020 May 20;30(3):461–473. doi: 10.1007/s00787-020-01532-5

Table 3.

Main treatment outcomes of treatment completers on T0 (pre-treatment), T1 (post-treatment) and T2 (2 months follow-up) (complete cases)

T0 T1 T2
Mean Range 95% CI SD Mean Range 95% CI SD Mean Range 95% CI SD

Total tic score

(YGTSS total (motoric + vocal) tic score, n = 13)

27.08 16–35 23.12–31.04 6.551 23.69 8–35 18.69–28.69 8.270 22.85 11–30 19.33–26.36 5.814

Motor tics

(YGTSS total motor tic score, n = 13)

15.92 10–20 13.85–17.99 3.427 13.46 0–20 10.40–16.52 5.060 12.46 6–17 7.14–13.63 3.072

Vocal tics

(YGTSS total vocal tic score, n = 13)

11.15 0–19 7.71–14.60 5.699 10.23 0–18 18.69–28.69 5.703 10.38 0–19 19.33–26.36 5.363

Impairment

(YGTSS impairment score, n = 13)

24.62 10–40 18.27–30.96 10.500 14.62 0–30 7.81–21.42 11.266 16.92 0–40 9.37–24.48 12.506

Global tic severity

(YGTSS global tic severity score, n = 13)

51.69 36–74 44.19–59.19 12.412 38.31 18–65 28.69–47.93 15.918 39.77 11–68 30.29–49.24 15.680

Quality of life

(C&A-GTS-QOL total problem score, n = 12)

58.92 30–92 45.08–72.75 21.78 50.42 28–88 38.59–62.25 18.62 47.00 31–83 35.24–58.76 18.51

Premonitory urges

(PUTS total score, n = 12)

21.17 15–32 18.20–24.13 4.67 20.58 9–28 16.91–24.25 5.78 20.58 11–31 16.69–24.48 6.13

Behavioral problems

(CBCL total score, n = 9)

45.11 7–91 23.09–67.13 28.6463 39.556 5–96 16.48–62.63 30.0213 28.56 4–59 12.20–44.91 21.2786
Treatment satisfaction (children forms, n = 13) 3.943 3.27–4.91 3.67–4.22 0.45628
Treatment satisfaction (parent forms, n = 13) 3.916 2.48–4.64 3.57–4.25 0.55926

95% CI 95% confidence interval for mean, YGTSS Yale Global Tic Severity Scale, PUTS Premonitory Urge for Tics Scale, C&A-GTS-QOL The Gilles De La Tourette Syndrome-Quality of Life Scale for Children and Adolescents, CBCL Children Behavior Checklist